Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02512757 · ClinicalTrials.gov registry record
A Case-Control Study to Verify Diagnostic Performance of AminoIndex™ Technology
A clinical trial, sponsored by Innovis.
- Completed
- Registry status
- 150
- Enrollment target
NCT02512757 is a clinical trial that has completed, run by Innovis. The registered enrollment target is 150 participants.
The verdict
NCT02512757 has completed, sponsored by Innovis.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
This is a prospective, multi-center study to evaluate the diagnostic performance characteristics of the AminoIndex™ technology among patients at high risk for developing lung cancer as compared with standard lung cancer screening and diagnostic procedures including low-dose CT, high-dose CT, biopsy and histopathology.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2015-08-13 |
| Est. Completion | 2017-07-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02512757
The ClinicalTrials.gov registry entry for NCT02512757 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Innovis, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02512757 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02512757 about?
NCT02512757 is a clinical study titled "A Case-Control Study to Verify Diagnostic Performance of AminoIndex™ Technology". This is a prospective, multi-center study to evaluate the diagnostic performance characteristics of the AminoIndex™ technology among patients at high risk for developing lung cancer as compared with standard lung cancer screening and diagnostic procedures including low-dose CT, high-dose CT, biopsy ...
What is the current status of trial NCT02512757?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2015-08-13. Estimated completion is 2017-07-17.
Who is sponsoring clinical trial NCT02512757?
This trial is sponsored by Innovis, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.